Close

BIO Statement on Biosimilar User Fee Act Goals Letter

Sep 26 2016
Washington, D.C. (September 16, 2016) – Biotechnology Innovation Organization (BIO) Senior Vice President for Science Policy Kay Holcombe released the following statement today regarding the Biosimilar User Fee Act (BsUFA) II goals letter:

BIO Applauds Senate Passage of Advancing Hope Act

Sep 23 2016
Washington, D.C. (September 23, 2016) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood released the following statement today regarding Senate passage of the Advancing Hope Act of 2016:

BIO Statement Regarding the UN High Level Panel on Access to Medicines Report

Sep 14 2016
Sadly the United Nations High Level Panel ignored the real issues that impact or delay delivery of innovative treatments and cures throughout the developing world, while focusing on policy recommendations in the one area – intellectual property – that would actually undermine ongoing research and development by hundreds of companies, universities and researchers.  

BIO Investor Forum 2016 Programming Announced

Sep 7 2016
BIO announced programming for the 15th annual BIO Investor Forum. Held on October 18-19 at the Westin St. Francis Hotel in San Francisco, the BIO Investor Forum explores global investment trends and opportunities in life sciences. Early and mid-stage private as well as emerging public companies poised for growth in 2017 are the focus of the event.

BIO Releases New Report on Renewable Chemical Biorefinery Commercialization

Sep 7 2016
BIO released the new report “Advancing the Biobased Economy: Renewable Chemical Biorefinery Commercialization, Progress, and Market Opportunities, 2016 and Beyond,” documenting substantial, ongoing growth in the renewable chemical industry and outlining federal and state policies that support the industry.

BIO Launches “Innovation Saves” Ad to Highlight Value of Biopharmaceutical Innovation

Sep 6 2016
BIO launched a new television ad focused on biopharmaceutical innovation and its unique ability to help both save lives and save money.  The new ad, along with its “Innovation Saves” website, is a new chapter in BIO’s Value Campaign, which seeks to highlight the value of biopharmaceutical innovation, the importance of protecting the ecosystem that makes new cures and treatments possible and ensuring that patients have access to these important innovations. 

Life Sciences Community Joins Rep. Charlie Dent to Discuss State of the Industry and Positive Impact on Pennsylvania

Aug 18 2016
Pennsylvania’s concentration of bioscience employment is nine percent greater than national average

Biotechnology Innovation Organization and Biominas Brasil to Co-Host BIO Latin America Conference

Aug 3 2016
Meeting will bring together biotechnology executives, academics and investors from around the globe 

New PBS Film and 2016 BIO Animal Biotech Summit Highlight Biotech Solutions to Combating Emerging Infectious Diseases

Aug 1 2016
Programming at this year’s Animal Biotech Summit, Advancing One Health through Biotechnology, will look at how biotechnology can be used in emerging infectious disease surveillance and rapid diagnosis, while highlighting the flexibility biotechnology provides for treating, controlling and preventing these diseases. The 2016 Summit will be held September 21-23, 2016 in Bethesda, Maryland. 

Pennsylvania Governor Wolf Signs Bill Facilitating Patient Access to Interchangeable Biologic Medicines

Jul 22 2016
BIO and Pennsylvania Bio commend Governor Tom Wolf for signing critical legislation to create a pathway for the substitution of interchangeable biologic medicines, with appropriate communication to patients and physicians.